Overview of the CNS pharmacology of BW 1370U87: A chemically novel, reversible, selective MAO-A inhibitor with potential to be a new antidepressant drug
- 1 January 1992
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 25 (3), 181-190
- https://doi.org/10.1002/ddr.430250302
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Blood pressure effects of monoamine oxidase inhibitors in response to orally administered tyramine in the ratDrug Development Research, 1992
- Potentiation of the behavioral effects of 5-hydroxytryptophan by BW 1370U87, a selective monoamine oxidase-A inhibitorDrug Development Research, 1992
- The Monoamine Oxidase Inhibitor—Tyramine InteractionThe Journal of Clinical Pharmacology, 1989
- Simple alternation of components in a multiple fixed‐interval fixed‐ratio schedule of food reinforcement in the ratDrug Development Research, 1988
- Metoclopramide potentiates d-amphetamine-induced hypermotility and stereotypy in ratPharmacology Biochemistry and Behavior, 1987
- An update on the identity crisis of monoamine oxidase: new and old evidence for the independence of mao A and BPharmacology & Therapeutics, 1985
- Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PATNature, 1983
- Effect of β-phenylethylamine and d-amphetamine on electrical self-stimulation of brainPharmacology Biochemistry and Behavior, 1976
- Alpha-noradrenergic receptor binding in mammalian brain: Differential labeling of agonist and antagonist statesLife Sciences, 1976
- Effect of central catecholamine alterations by 6-hydroxydopamine on shuttle box avoidance acquistionPhysiology & Behavior, 1972